Product Information
MENEST 0.3 MG TABLET is a brand (anda) product labeled by Pfizer Inc., priced at $1.8168 per EA under NDC 61570007201. Its NADAC has been published 288 times since Nov 28, 2013.
Strength
.3 mg/1
Manufacturer
Pfizer Inc.NDC
61570007201
Classification
Brand (ANDA)
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
10/22/2025
Active Ingredients
ESTROGENS, ESTERIFIEDApproval Type
Generic (ANDA)
FDA Application
ANDA084951On Market Since
9/28/1977
Price Statistics
The NADAC for MENEST 0.3 MG TABLET has been published 288 times since Nov 28, 2013, and over the history we have for it it has risen 115.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8168 per EA |
|---|---|
| All-time high | $1.8168 (Feb 25, 2026) |
| All-time low | $0.8433 (Nov 28, 2013) |
| 52-week high | $1.8168 |
| 52-week low | $1.8168 |
| Median price | $1.3091 |
| Average price | $1.3402 |
| Largest weekly change | +20.0% (Jan 6, 2016) |
| Weeks tracked | 288 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the esterified estrogens market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MENEST 0.3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MENEST 0.3 MG TABLET, manufactured by Pfizer Inc., is $1.8168 per EA (NDC 61570007201), effective Feb 25, 2026.
How has the price of MENEST 0.3 MG TABLET changed over time?
Over the history we have for it, the NADAC for MENEST 0.3 MG TABLET has risen 115.4%. It has been tracked across 288 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MENEST 0.3 MG TABLET?
Since Nov 28, 2013, the NADAC for MENEST 0.3 MG TABLET has ranged from a low of $0.8433 (Nov 28, 2013) to a high of $1.8168 (Feb 25, 2026), with a median of $1.3091 per EA.
Are there cheaper alternatives to MENEST 0.3 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MENEST 0.3 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures MENEST 0.3 MG TABLET?
MENEST 0.3 MG TABLET (NDC 61570007201) is labeled by Pfizer Inc., and CMS classifies it as a brand (anda) product.
Related Drugs
Same classification